Eyebright Medical Technology Beijing Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 1.51%

Eyebright Medical Technology Beijing Co Ltd (688050) has an Asset Resilience Ratio of 1.51% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688050 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

CN¥72.13 Million
≈ $10.55 Million USD Cash + Short-term Investments

Total Assets

CN¥4.76 Billion
≈ $697.26 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Eyebright Medical Technology Beijing Co Ltd's Asset Resilience Ratio has changed over time. See Eyebright Medical Technology Beijing Co balance sheet quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Eyebright Medical Technology Beijing Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Eyebright Medical Technology Beijing Co (688050) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥72.13 Million 1.51%
Total Liquid Assets CN¥72.13 Million 1.51%

Asset Resilience Insights

  • Limited Liquidity: Eyebright Medical Technology Beijing Co Ltd maintains only 1.51% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Eyebright Medical Technology Beijing Co Ltd Industry Peers by Asset Resilience Ratio

Compare Eyebright Medical Technology Beijing Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Tecan Group AG
SW:TECN
Medical Instruments & Supplies 20.48%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
Medical Instruments & Supplies 38.45%
Formosa Optical Technology Co Ltd
TWO:5312
Medical Instruments & Supplies 46.32%
ZEN Graphene Solutions Ltd
V:ZEN
Medical Instruments & Supplies 4.79%
GETS Global Bhd
KLSE:5079
Medical Instruments & Supplies 0.03%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%

Annual Asset Resilience Ratio for Eyebright Medical Technology Beijing Co Ltd (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Eyebright Medical Technology Beijing Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 4.28% CN¥166.33 Million
≈ $24.34 Million
CN¥3.89 Billion
≈ $568.92 Million
+0.50pp
2024-12-31 3.78% CN¥132.27 Million
≈ $19.36 Million
CN¥3.50 Billion
≈ $511.72 Million
+3.13pp
2023-12-31 0.66% CN¥20.12 Million
≈ $2.94 Million
CN¥3.06 Billion
≈ $448.04 Million
-20.82pp
2022-12-31 21.47% CN¥481.97 Million
≈ $70.53 Million
CN¥2.24 Billion
≈ $328.43 Million
+21.45pp
2021-12-31 0.02% CN¥478.90K
≈ $70.08K
CN¥2.05 Billion
≈ $299.63 Million
+0.01pp
2020-12-31 0.02% CN¥278.08K
≈ $40.69K
CN¥1.64 Billion
≈ $239.77 Million
-0.44pp
2018-12-31 0.45% CN¥2.65 Million
≈ $388.39K
CN¥586.45 Million
≈ $85.82 Million
--
pp = percentage points

About Eyebright Medical Technology Beijing Co Ltd

SHG:688050 China Medical Instruments & Supplies
Market Cap
$1.10 Billion
CN¥7.53 Billion CNY
Market Cap Rank
#8653 Global
#2148 in China
Share Price
CN¥38.91
Change (1 day)
-0.82%
52-Week Range
CN¥38.91 - CN¥82.40
All Time High
CN¥385.84
About

Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company offers intraocular, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also provides solutions for opht… Read more